BBP
INO icon

Banco BTG Pactual’s Inovio Pharmaceuticals INO Stock Holding History

Banco BTG Pactual’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,667
Closed -$143K – 79
2021
Q3 		$143K Hold
1,667
– – 0.06% 96
2021
Q2 		$185K Hold
1,667
– – 0.12% 86
2021
Q1 		$186K Buy
+1,667
New +$219K 0.06% 98

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Banco BTG Pactual's INO Position: Q4 2021 in Review

Banco BTG Pactual sold out of Inovio Pharmaceuticals (INO) in Q4 2021, closing a stake of 1,667 shares — an estimated $143K sold.

Banco BTG Pactual first reported a position in INO in Q1 2021 and held it in 3 quarters. The position peaked at $186K in Q1 2021. 208 funds tracked by Wall St. Rank hold INO as of Q4 2021.

  • Banco BTG Pactual reported no remaining Inovio Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Banco BTG Pactual sold 1,667 Inovio Pharmaceuticals shares in Q4 2021, an estimated $143K.
  • Banco BTG Pactual first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Banco BTG Pactual's Inovio Pharmaceuticals position peaked at $186K in Q1 2021.
  • 208 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2021.

Based on Banco BTG Pactual's 13F filing for Q4 2021, filed 12 May 2022.